The 20 Best Cholangiocarcinoma (Bile Duct Cancer) Doctors in The United States

I enjoy traveling, dancing and food. Dr. Shroff is rated as an Elite provider by MediFind in the treatment of Cholangiocarcinoma (Bile Duct Cancer). She is also highly rated in 11 other conditions, according to our data. Her clinical expertise encompasses Cholangiocarcinoma (Bile Duct Cancer), Pancreatic Cancer, Pancreatic Ductal Adenocarcinoma, Pancreaticoduodenectomy, and Pancreatectomy. Dr. Shroff is board certified in American Board Of Internal Medicine/Medical Oncology. Dr. Shroff is currently accepting new patients.

Shishir Maithel is a Surgical Oncologist practicing medicine in Chicago, Illinois. He has been practicing medicine for over 26 years. Dr. Maithel is rated as an Elite provider by MediFind in the treatment of Cholangiocarcinoma (Bile Duct Cancer). He is also highly rated in 29 other conditions, according to our data. His clinical expertise encompasses Cholangiocarcinoma (Bile Duct Cancer), Gallbladder Cancer, Pancreatic Islet Cell Tumor, Pancreaticoduodenectomy, and Hepatectomy. Dr. Maithel is board certified in American Board Of Surgery - Surgery (Certified).

Dr. Nilofer S. Azad is Professor of Oncology at Johns Hopkins University School of Medicine and serves as the Associate Cancer Center Director for Clinical Research for the Johns Hopkins Sidney Kimmel Cancer Center. Dr. Azad earned her medical degree and completed a residency in internal medicine at Baylor College of Medicine in Houston, Texas. She then completed a fellowship in oncology and hematology at the National Institute of Health's National Cancer Institute in Bethesda, Maryland where she served as chief fellow. Dr. Azad’s research focused on early phase drug development and the intersection of moving exciting laboratory findings into patients for new treatment options Dr. Azad joined the faculty at the Kimmel Cancer Center in 2008. Dr. Azad’s clinical expertise is in cancers of the gastrointestinal tract, with a concentration in colorectal cancer, cholangiocarcinoma and pancreaticobiliary tract cancer. Her research efforts are dedicated to developing new drug combinations for patients with advanced cancer. In particular, Dr. Azad’s laboratory and clinical trials explore epigenetic therapy in combination with chemotherapy and immunotherapy to improve survival for patients, as well as molecularly targeted drugs. She is an active clinical trialist, leading multiple clinical trials of molecularly targeted agents for advanced cancer patients. Dr. Azad has received numerous grants for her work from entities such as the NCI (National Cancer Center), American Cancer Society, American Society of Clinical Research, Breakthrough Cancer Foundation, the Lustgarten Foundation, The Gateway Foundation, and the National Comprehensive Cancer Network, among others. She served as Principal for Johns Hopkins on the AACR Stand Up 2 Cancer Colorectal Cancer Dream Team and is a member of the Stand Up 2 Cancer Epigenetics Dream Team, leading the GI cancer initiatives for the group. Dr. Azad is a national leader in GI cancer, including serving as a member of the national NCI Colon Cancer Task Force and as Co-Chair of the Scientific and Medical Advisory Board for the Cholangiocarcinoma Foundation. She has a presidential appointment to the National Cancer Advisory Board. Dr. Azad is rated as an Elite provider by MediFind in the treatment of Cholangiocarcinoma (Bile Duct Cancer). She is also highly rated in 18 other conditions, according to our data. Her clinical expertise encompasses Cholangiocarcinoma (Bile Duct Cancer), Colorectal Cancer, Pancreatic Cancer, Hepato-Pancreato-Biliary Surgery, and Colonoscopy. Dr. Azad is board certified in American Board Of Internal Medicine.

Kamran Idrees is a Colorectal Surgeon practicing medicine in Nashville, Tennessee. Dr. Idrees is rated as an Elite provider by MediFind in the treatment of Cholangiocarcinoma (Bile Duct Cancer). He is also highly rated in 25 other conditions, according to our data. His clinical expertise encompasses Neuroendocrine Tumor, Pancreatic Islet Cell Tumor, Gallbladder Cancer, Pancreaticoduodenectomy, and Pancreatectomy.

I am a cancer surgeon who specializes in treating patients with pre-cancerous and cancerous conditions of the pancreas, liver, bile ducts, stomach, and adrenal glands. I initially trained and practiced at Walter Reed Army Medical Center in Washington, D.C. During this time, I served one year on a forward surgical team in Iraq. Following this service, I practiced for 13 years as a surgical oncologist at Memorial Sloan Kettering Cancer Center in New York. In 2018, I joined the faculty at Duke University and now serve as the chief of surgical oncology for Duke Health. I enjoy getting to know my patients and delivering the highest quality of cancer care. I am dedicated not only to treating and curing your cancer, but also providing you with the highest quality of life. Operations for cancers within the abdomen are a serious undertaking, and I am committed to making sure that they are performed with the highest level of expertise. Dr. Allen is rated as an Elite provider by MediFind in the treatment of Cholangiocarcinoma (Bile Duct Cancer). He is also highly rated in 33 other conditions, according to our data. His clinical expertise encompasses Pancreatic Cancer, Cholangiocarcinoma (Bile Duct Cancer), Familial Pancreatic Cancer, Pancreatectomy, and Hepatectomy. Dr. Allen is board certified in American Board Of Surgery, General Surgery.

Theodore Hong is a Radiologist practicing medicine in Needham, Massachusetts. Dr. Hong is rated as an Elite provider by MediFind in the treatment of Cholangiocarcinoma (Bile Duct Cancer). He is also highly rated in 23 other conditions, according to our data. His clinical expertise encompasses Pancreatic Cancer, Anal Cancer, Cholangiocarcinoma (Bile Duct Cancer), Pancreaticoduodenectomy, and Tissue Biopsy. Dr. Hong is board certified in American Board Of Radiology.

Dr. Mark Yarchoan is a physician–scientist based in Baltimore who specializes in the treatment and study of gastrointestinal cancers, with a particular focus on liver malignancies, including hepatocellular carcinoma (HCC) and cholangiocarcinoma (CCA). He received his undergraduate degree from Amherst College and his medical degree from the Perelman School of Medicine at the University of Pennsylvania. He completed his residency in internal medicine at the Hospital of the University of Pennsylvania, followed by a fellowship in medical oncology at the Johns Hopkins University School of Medicine, where he joined the faculty in 2018. Dr. Yarchoan leads a research laboratory dedicated to developing novel immunotherapies for liver cancers. His translational research program integrates analyses of clinical trial biospecimens with preclinical modeling to identify and overcome barriers to effective antitumor immunity. A major focus of his work is the development of therapeutic cancer vaccines for hepatobiliary malignancies. He serves as Principal Investigator on multiple clinical trials for hepatobiliary cancers, contributes to international guideline committees for liver cancer, and is a member of the Johns Hopkins Graduate Training Programs in Cellular and Molecular Medicine and Immunology. Dr. Yarchoan’s contributions have been recognized with numerous honors, including the ASCO Young Investigator Award, the Conquer Cancer Foundation Career Development Award, the Mark R. Clements Award from the Cholangiocarcinoma Foundation, and the Blue Faery Award for Excellence in Liver Cancer Research. Dr. Yarchoan is rated as an Elite provider by MediFind in the treatment of Cholangiocarcinoma (Bile Duct Cancer). He is also highly rated in 4 other conditions, according to our data. His clinical expertise encompasses Fibrolamellar Carcinoma, Cholangiocarcinoma (Bile Duct Cancer), Liver Cancer, Pancreatic Cancer, and Hepatectomy. Dr. Yarchoan is board certified in American Board Of Internal Medicine.

Federico Aucejo is a Transplant Surgeon practicing medicine in Cleveland, Ohio. Dr. Aucejo is rated as an Elite provider by MediFind in the treatment of Cholangiocarcinoma (Bile Duct Cancer). He is also highly rated in 25 other conditions, according to our data. His clinical expertise encompasses Liver Cancer, Cholangiocarcinoma (Bile Duct Cancer), Liver Failure, Liver Transplant, and Hepatectomy.

Ronald Dematteo is a General Surgeon practicing medicine in Radnor, Pennsylvania. Dr. Dematteo is rated as an Elite provider by MediFind in the treatment of Cholangiocarcinoma (Bile Duct Cancer). He is also highly rated in 24 other conditions, according to our data. His clinical expertise encompasses Gastrointestinal Stromal Tumor, Cholangiocarcinoma (Bile Duct Cancer), Pancreatic Cancer, Hepatectomy, and Pancreatectomy. Dr. Dematteo is board certified in Surgery, 1998. Dr. Dematteo is currently accepting new patients.

Timothy Pawlik is a Surgical Oncologist practicing medicine in Columbus, Ohio. Dr. Pawlik is rated as an Elite provider by MediFind in the treatment of Cholangiocarcinoma (Bile Duct Cancer). He is also highly rated in 41 other conditions, according to our data. His clinical expertise encompasses Pancreatic Cancer, Gallbladder Adenocarcinoma, Cholangiocarcinoma (Bile Duct Cancer), Hepato-Pancreato-Biliary Surgery, and Pancreaticoduodenectomy.

Todd Bauer is a Surgical Oncologist practicing medicine in Charlottesville, Virginia. Dr. Bauer is rated as an Elite provider by MediFind in the treatment of Cholangiocarcinoma (Bile Duct Cancer). He is also highly rated in 36 other conditions, according to our data. His clinical expertise encompasses Cholangiocarcinoma (Bile Duct Cancer), Pancreatic Cancer, Neuroendocrine Tumor, Hepatectomy, and Pancreaticoduodenectomy.

Charles Scoggins is a Surgical Oncologist practicing medicine in Louisville, Kentucky. He has been practicing medicine for over 31 years. Dr. Scoggins is rated as an Elite provider by MediFind in the treatment of Cholangiocarcinoma (Bile Duct Cancer). He is also highly rated in 39 other conditions, according to our data. His clinical expertise encompasses Cholangiocarcinoma (Bile Duct Cancer), Gallbladder Cancer, Gallbladder Disease, Hepatectomy, and Pancreatectomy. Dr. Scoggins is board certified in American Board Of Surgery, Surgery (General Surgery) - 2003. Dr. Scoggins is currently accepting new patients.

Rory Smoot is a General Surgeon practicing medicine in Rochester, Minnesota. Dr. Smoot is rated as an Elite provider by MediFind in the treatment of Cholangiocarcinoma (Bile Duct Cancer). He is also highly rated in 16 other conditions, according to our data. His clinical expertise encompasses Cholangiocarcinoma (Bile Duct Cancer), Pancreatic Cancer, Pancreatic Islet Cell Tumor, Pancreatectomy, and Hepatectomy.

Daniel Ahn is a Hematologist and an Oncologist practicing medicine in Phoenix, Arizona. Dr. Ahn is rated as an Elite provider by MediFind in the treatment of Cholangiocarcinoma (Bile Duct Cancer). He is also highly rated in 18 other conditions, according to our data. His clinical expertise encompasses Cholangiocarcinoma (Bile Duct Cancer), Colorectal Cancer, Pancreatic Cancer, and Neuroendocrine Tumor.

Ching-wei Tzeng is a General Surgeon practicing medicine in Houston, Texas. Dr. Tzeng is rated as an Elite provider by MediFind in the treatment of Cholangiocarcinoma (Bile Duct Cancer). He is also highly rated in 30 other conditions, according to our data. His clinical expertise encompasses Pancreatic Cancer, Cholangiocarcinoma (Bile Duct Cancer), Pancreatic Ductal Adenocarcinoma, Hepatectomy, and Pancreatectomy.

Julie Heimbach is a Transplant Surgeon practicing medicine in Rochester, Minnesota. Dr. Heimbach is rated as an Elite provider by MediFind in the treatment of Cholangiocarcinoma (Bile Duct Cancer). She is also highly rated in 15 other conditions, according to our data. Her clinical expertise encompasses Cholangiocarcinoma (Bile Duct Cancer), Sclerosing Cholangitis, Liver Failure, Liver Transplant, and Kidney Transplant.

Funda Meric is a General Surgeon and a Surgical Oncologist practicing medicine in Houston, Texas. Dr. Meric is rated as an Elite provider by MediFind in the treatment of Cholangiocarcinoma (Bile Duct Cancer). She is also highly rated in 19 other conditions, according to our data. Her clinical expertise encompasses PIK3CA-Related Overgrowth Spectrum, Breast Cancer, Cholangiocarcinoma (Bile Duct Cancer), Triple-Negative Breast Cancer, and Mastectomy.

Dr. Zalupski is an Professor of Medicine in the division of Medical Oncology at the UMMC. He completed medical school, an internal medicine residency and a medical oncology fellowship at Wayne State University in Detroit. Dr. Zalupski's clinical and research interest is in experimental therapeutics of gastrointestinal malignancies and sarcomas. He also serves as the medical director of the Multidisciplinary Pancreatic Cancer Clinic. Dr. Zalupski is rated as an Elite provider by MediFind in the treatment of Cholangiocarcinoma (Bile Duct Cancer). He is also highly rated in 19 other conditions, according to our data. His clinical expertise encompasses Pancreatic Cancer, Cholangiocarcinoma (Bile Duct Cancer), Neuroendocrine Tumor, Familial Pancreatic Cancer, and Pancreaticoduodenectomy. Dr. Zalupski is board certified in Internal Medicine and Medical Oncology.

Kelsey Klute is a Hematologist and an Oncologist practicing medicine in Omaha, Nebraska. She has been practicing medicine for over 16 years. Dr. Klute is rated as a Distinguished provider by MediFind in the treatment of Cholangiocarcinoma (Bile Duct Cancer). She is also highly rated in 19 other conditions, according to our data. Her clinical expertise encompasses Pancreatic Cancer, Colorectal Cancer, Familial Pancreatic Cancer, and Familial Colorectal Cancer.

Dr. Somasundaram Subramaniam is a Medical Oncologist at the Swedish Cancer Institute in Seattle, Washington and a 2021 Seattle Met Top Doctor Award winner. He has specialized expertise in the management of Gastrointestinal (GI) Cancers. This includes common cancers like colon and rectal cancers and also less common cancers like stomach cancer, neuroendocrine tumors (NETs) and liver and bile duct cancers. He also treats patients with lung cancer and kidney cancer. Dr. Soma chose to pursue a career in Oncology to help patients diagnosed with very serious illnesses and their families by providing hope, education and the best opportunities for treatment and cure. He is thrilled to be working with at Swedish, which has an excellent group of caring and highly-trained physicians, nurses and providers who all work very closely together with a robust multi-disciplinary team approach.. Dr. Subramaniam is an investigator on several clinical trials and a key member of the Personalized Medicine Research Program at Swedish, which focuses on the using a tumor’s DNA mutations to target it with newer drugs. The Swedish Cancer Institute prioritizes opening cutting-edge clinical trials to ensure patients have access to the latest innovations in cancer therapy. Dr. Subramaniam graduated from medical school at the National University of Singapore and obtained sub-specialty training during his fellowship at Stanford University, which was supported by a T32 training grant awarded by the National Institutes of Health. He is board-certified in Internal Medicine and Medical Oncology. Dr. Subramaniam also earned a Master of Science degree in Epidemiology and Clinical Research from Stanford. In addition to treating patients with cancer, Dr. Subramaniam is the Medical Director of the Cancer Control program, which emphasizes preventative measures and appropriate cancer screening, to reduce the incidence and burden of cancer in our community. Dr. Subramaniam is rated as a Distinguished provider by MediFind in the treatment of Cholangiocarcinoma (Bile Duct Cancer). He is also highly rated in 23 other conditions, according to our data. His clinical expertise encompasses Pancreatic Cancer, Familial Pancreatic Cancer, Colorectal Cancer, Nerve Decompression, and Laminectomy. Dr. Subramaniam is board certified in American Board Of Internal Medicine. Dr. Subramaniam is currently accepting new patients.